Adaptimmune Receives Positive Opinion for Orphan Drug Designation in the European Union for SPEAR™ T-cell Therapy Targeting NY-ESO for Treatment of Soft Tissue Sarcoma Biotech Investing
VBI Vaccines to Present at the Virus-Like Particle and Nano-Particle Vaccines Conference Biotech Investing
BIND Therapeutics Announces Resignation of Directors Affiliated with Polaris Partners Biotech Investing
UPDATE — Cantabio Pharmaceuticals and University of Antioquia Collaborate to Research Company’s Therapeutic Candidates Targeting DJ-1 Protein to Treat Parkinson’s Disease Biotech Investing
Cascadian Therapeutics Reports Topline ONT-380 "Triplet" Data and Outlines Key Development Strategies Biotech Investing
